Kenneth Cundy
Chief Tech/Sci/R&D Officer at ANEBULO PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Kenneth C.
Cundy is currently the Chief Scientific Officer at Anebulo Pharmaceuticals, Inc. He was previously the Chief Scientific Officer at CohBar, Inc. and the Chief Scientific Officer at XenoPort, Inc. He also worked as a Senior Director-Biopharmaceutics at Gilead Sciences, Inc. Dr. Cundy received his undergraduate degree from The University of Manchester and his doctorate from the University of Kentucky.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-28 | 0 ( -.--% ) | - $ | 2024-03-30 |
Kenneth Cundy active positions
| Companies | Position | Start |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-05-19 |
Former positions of Kenneth Cundy
| Companies | Position | End |
|---|---|---|
| COHBAR, INC. | Chief Tech/Sci/R&D Officer | 2022-03-30 |
| XENOPORT, INC. | Corporate Officer/Principal | 2014-10-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 1999-12-31 |
Training of Kenneth Cundy
| The University of Manchester | Undergraduate Degree |
| University of Kentucky | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| COHBAR, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Kenneth Cundy